Fellowship · New Brunswick, NJ
Sponsored by Rutgers Health
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
ESMO open · 2022 · 289 citations · Gregory Riedlinger
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature · 2022 · 98 citations · Gregory Riedlinger
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes.
Nature communications · 2025 · 14 citations · Gregory Riedlinger
The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer.
Cancer research communications · 2024 · 26 citations · Gregory Riedlinger
Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases.
Nature genetics · 2026 · 5 citations · Gregory Riedlinger
Frontline Science: AMPK regulates metabolic reprogramming necessary for interferon production in human plasmacytoid dendritic cells.
Journal of leukocyte biology · 2021 · 46 citations · Pratik Deb
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms.
Blood cancer journal · 2024 · 18 citations · Payal Sojitra
Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer.
Clinical and translational medicine · 2023 · 19 citations · Gregory Riedlinger